Dc Global Ventures
SEC-registered investment adviser.
- Website
- HTTP://WWW.DECHENG.COM
- HQ
- CA
Dc Global Ventures, operating as Decheng Capital, is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and to growth stage healthcare companies with a strong market presence. The firm lists a team of founders, managing directors, partners, and vice presidents.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Seed, Series A, Growth | Not enough dated deals | Growth, Series A, Series B |
| Sectors | Healthtech, Biotech, Medical devices, Life sciences and research tools | Not enough dated deals | Biotech, Healthtech, Medical devices, Life sciences and research tools |
| Regions | Global | Not enough dated deals | CA, MA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2012 | 1 | Biotech, Medical devices |
| 2013 | 2 | Biotech, Healthtech, Medical devices |
| 2014 | 2 | Biotech, Healthtech, Medical devices |
| 2016 | 4 | Healthtech, Biotech, Medical devices |
| 2017 | 5 | Biotech, Healthtech, Consumer |
| 2018 | 7 | Biotech, Healthtech, Medical devices |
| 2019 | 6 | Biotech, Healthtech, Medical devices |
| 2020 | 7 | Biotech, Healthtech, Medical devices |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2012 | 0 | 0 | 1 | 0 | 0 |
| 2013 | 0 | 0 | 1 | 1 | 0 |
| 2014 | 0 | 0 | 0 | 1 | 1 |
| 2015 | 0 | 0 | 0 | 0 | 0 |
| 2016 | 0 | 0 | 2 | 1 | 1 |
| 2017 | 0 | 0 | 2 | 1 | 2 |
| 2018 | 0 | 0 | 0 | 4 | 2 |
| 2019 | 0 | 0 | 4 | 0 | 1 |
| 2020 | 0 | 0 | 0 | 2 | 5 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Decheng Capital Global Life Sciences Fund V, L.P. Provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with strong market presence. Inferred from the firm's website | 2024 | $452M to $700M (Form D) | Open, writing first checks |
| Decheng Capital Global Life Sciences Fund IV, L.P. | approx. 2020 | $650M (Form D) | Follow-ons only |
03 · People across funds
- Fengying Yu, Manager of the General Partner of the Issuer
Decheng Capital Global Life Sciences Fund IV, L.P. (Named on Form D)
- Xiangmin Cui, Manager of the General Partner of the Issuers
Decheng Capital Global Life Sciences Fund V, L.P. (Named on Form D); Decheng Capital Global Life Sciences Fund IV, L.P. (Named on Form D)
- Yuheng Qiu, Manager of the General Partner of the Issuers
Decheng Capital Global Life Sciences Fund V, L.P. (Named on Form D)
- Aaron Li, MBA, Principal
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Claire Zhang, M.B.A., Senior Associate
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Dayton Misfeldt, Partner
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Joan Chen, Ph.D., Vice President
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Michael Notaras, Ph.D., Vice President
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Min Cui, Ph.D., Founder and Managing Director
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Nick Pliam, M.D., Ph.D., Venture Partner
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Peter Colabuono, Managing Director
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Qiang Xu, Ph.D., Partner
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Shengyang Jin, Ph.D., Vice President
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Tony Tong, Ph.D., Partner
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Victor Tong, Jr., Managing Director
Decheng Capital Global Life Sciences Fund V, L.P. (Team); Decheng Capital Global Life Sciences Fund IV, L.P. (Team)
- Wei Xu, Partner
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026